ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000615.1|TP-1161_1 # 1 # 2418 # 1 # ID=1_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.664	BGC0000615.1|TP-1161_1 	1	2418	+	Loose	2300	1315.06	Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin	78.84	3003283	protein variant model	D516G, H526T, L511R, N518I	A473T:90, I837V:5750	rifamycin antibiotic	antibiotic target alteration; antibiotic target replacement	rifamycin-resistant beta-subunit of RNA polymerase (rpoB)	GACCACTTCGGCAACCGCCGTCTGCGCACCGTCGGCGAGCTCATCCAGAACCAGGTCCGTCTGGGTCTGGCCCGGATGGAGCGCGTCGTCCGCGAGCGGATGACCACTCAGGACGTCGAGGCGATCACGCCGCAGACCCTGATCAACATCCGTCCCGTCGTCGCCTCCATCAAGGAGTTCTTCGGCACCTCGCAGCTGTCCCAGTTCATGGACCAGACCAACCCGCTCGCGGGTCTGACCCACAAGCGCCGCCTCTCGGCGCTGGGTCCGGGCGGTCTGTCCCGTGAGCGCGCGGGCTTCGAGGTCCGAGACGTCCACCCGTCCCACTACGGCCGTATGTGCCCGATCGAGACCCCCGAAGGTCCGAACATCGGTCTGATCGGTTCGCTCGCCGCCTACGGCCGGGTGAACTCCTTCGGTTTCGTGGAGACCCCCTACCGCAAGGTCATCGACGGTCGCATCAGCGACCAGATCGACTACCTGACCGCGGACGAGGAGGACCTCTACGTCATCGCGCAGGCCAACACGCCGCTGAACGCCGACGGGAGCTTCGCCGAGTCGGGTGTGCTCGTGCGCCGTAAGGGCGGGGAGTTCGAGCAGGTCGACACCTCCGAGGTCGACTACATGGACGTGTCGCCGCGCCAGATGGTGTCGGTCGCCACCGCCATGATCCCCTTCCTGGAGCACGACGACGCCAACCGCGCGCTCATGGGTTCCAACATGCAGCGCCAGGCCGTGCCGCTGCTGCGCGCCGAGGCGCCCTTCGTCGGTACCGGCATGGAGTACCGCGCCGCCACCGACGCCGGTGAGGTCATCCTCGCCGAGAAGGCCGGTGTGGTCGAGGACGTCACCGCCGACTACGTCACCGTGATGGCCGACGACGGCACGCGCAAGACGTACCGGATGGGCAAGTTCCAGCGCTCCAACCAGGGCACCTGCTTCAACCAGCGCCCCATCGTCCACGAGGGCCAGCGGGTCGAGGTCAAGCAGGTCCTGGCCGACGGTCCGTCCACGGACCAGGGCGAGATGTCGCTGGGCAAGAACCTCCTCGTGGCGTACATGTCCTGGGAGGGCCACAACTACGAGGACGCGATCATCCTCTCCCAGCGTCTGGTGCAGGACGACGTCCTCTCCTCGATCCACATCGAGGAGCACGAGGTCGACGCCCGTGACACCAAGCTGGGCCCGGAGGAGATCACCCGCGAGATCCCCAACGTCAGCGAGGAGGTCCTGGCCGACCTCGACGACCGGGGCATCATCCGCATCGGCGCCGAGGTCGTCGACGGCGACATCCTCGTCGGCAAGGTCACGCCCAAGGGTGAGACCGAGCTGACCCCGGAGGAGCGTCTTCTGCGCGCCATCTTCGGTGAGAAGGCCCGCGAGGTCCGCGACACCTCCCTGAAGGTCCCGCACGGCGAGACCGGCAAGGTCATCGGCGTCCGCGTCTTCAGCCGCGAGGAGGGCGACGAGCTCGCCCCCGGCGTCAACGAGATGGTCCGGGTCTACGTCGCCCAGAAGCGCAAGATCACCGACGGTGACAAGCTCGCCGGTCGTCACGGCAACAAGGGCGTCATCGCCAAGATCCTGCCCCAGGAGGACATGCCCTTCCTGGAGGACGGCACCCCGGTCGACATCATCCTCAACCCGCTCGGTGTTCCCGGTCGTATGAACGTCGGCCAGGTACTGGAGGTCCACCTGGGCTGGCTGGCCAAGAACGGCTGGGTGGTCGAGGGGACCGAGGAGGAATGGCAGAAGTCGCTGCACGCGATCGGCGCGTCCGACGTCGAGCCGAACTCCCGTGTGGCCACGCCGGTCTTCGACGGCCTGCACGGCGACGAGCTGAGCGGCCTCATCAAGTCGGTCCGCCCGAACAAGGACGGCAACCGTCTCATCAACGACGACGGCAAGGCCCGCCTGTTCGACGGTCGTACCGGTGAGCCCTTCGCCGAGCCGATCTCCGTCGGTTACAAGTACATCCTGAAGCTCCACCACCTCGTGGACGACAAGATCCACGCCCGCTCCACCGGTCCGTACTCCATGATCACGCAGCAGCCGCTGGGTGGTAAGGCGCAGTTCGGTGGTCAGCGCTTCGGTGAGATGGAGGTCTGGGCGCTGGAGGCCTACGGTGCCGCCTACGCGCTCCAGGAGCTGCTCACCATCAAGTCCGACGACGTGGTGGGTCGCGTCAAGGTCTACGAGGCCATCGTCAAGGGCGAGAACATCCCCGAGCCGGGCATCCCTGAGTCCTTCAAGGTGCTCATCAAGGAGATGCAGTCGCTCTGTCTGAACGTGGAGGTGCTGTCCAGTGACGGTATGTCCATCGAGATGCGGGACAGCGACGAGGACGTCTTCCGCGCCGCGGAAGAACTGGGAATCGACCTGGGTCGGCGCGAGCCGAGCAGTGTCGAAGAGGTCTAA	DHFGNRRLRTVGELIQNQVRLGLARMERVVRERMTTQDVEAITPQTLINIRPVVASIKEFFGTSQLSQFMDQTNPLAGLTHKRRLSALGPGGLSRERAGFEVRDVHPSHYGRMCPIETPEGPNIGLIGSLAAYGRVNSFGFVETPYRKVIDGRISDQIDYLTADEEDLYVIAQANTPLNADGSFAESGVLVRRKGGEFEQVDTSEVDYMDVSPRQMVSVATAMIPFLEHDDANRALMGSNMQRQAVPLLRAEAPFVGTGMEYRAATDAGEVILAEKAGVVEDVTADYVTVMADDGTRKTYRMGKFQRSNQGTCFNQRPIVHEGQRVEVKQVLADGPSTDQGEMSLGKNLLVAYMSWEGHNYEDAIILSQRLVQDDVLSSIHIEEHEVDARDTKLGPEEITREIPNVSEEVLADLDDRGIIRIGAEVVDGDILVGKVTPKGETELTPEERLLRAIFGEKAREVRDTSLKVPHGETGKVIGVRVFSREEGDELAPGVNEMVRVYVAQKRKITDGDKLAGRHGNKGVIAKILPQEDMPFLEDGTPVDIILNPLGVPGRMNVGQVLEVHLGWLAKNGWVVEGTEEEWQKSLHAIGASDVEPNSRVATPVFDGLHGDELSGLIKSVRPNKDGNRLINDDGKARLFDGRTGEPFAEPISVGYKYILKLHHLVDDKIHARSTGPYSMITQQPLGGKAQFGGQRFGEMEVWALEAYGAAYALQELLTIKSDDVVGRVKVYEAIVKGENIPEPGIPESFKVLIKEMQSLCLNVEVLSSDGMSIEMRDSDEDVFRAAEELGIDLGRREPSSVEEV	MADSRQSKTAASPSPSRPQSSSNNSVPGAPNRVSFAKLREPLEVPGLLDVQTDSFEWLIGSPRWRESAAERGDVNPVGGLEEVLYELSPIEDFSGSMSLSFSDPRFDDVKAPVDECKDKDMTYAAPLFVTAEFINNNTGEIKSQTVFMGDFPMMTEKGTFIINGTERVVVSQLVRSPGVYFDETIDKSTDKTLHSVKVIPSRGAWLEFDVDKRDTVGVRIDRKRRQPVTVLLKALGWTSEQIVERFGFSEIMRSTLEKDNTVGTDEALLDIYRKLRPGEPPTKESAQTLLENLFFKEKRYDLARVGRYKVNKKLGLHVGEPITSSTLTEEDVVATIEYLVRLHEGQTTMTVPGGVEVPVETDDIDHFGNRRLRTVGELIQNQIRVGMSRMERVVRERMTTQDVEAITPQTLINIRPVVAAIKEFFGTSQLSQFMDQNNPLSGLTHKRRLSALGPGGLSRERAGLEVRDVHPSHYGRMCPIETPEGPNIGLIGSLSVYARVNPFGFIETPYRKVVDGVVSDEIVYLTADEEDRHVVAQANSPIDADGRFVEPRVLVRRKAGEVEYVPSSEVDYMDVSPRQMVSVATAMIPFLEHDDANRALMGANMQRQAVPLVRSEAPLVGTGMELRAAIDAGDVVVAEESGVIEEVSADYITVMHDNGTRRTYRMRKFARSNHGTCANQCPIVDAGDRVEAGQVIADGPCTDDGEMALGKNLLVAIMPWEGHNYEDAIILSNRLVEEDVLTSIHIEEHEIDARDTKLGAEEITRDIPNISDEVLADLDERGIVRIGAEVRDGDILVGKVTPKGETELTPEERLLRAIFGEKAREVRDTSLKVPHGESGKVIGIRVFSREDEDELPAGVNELVRVYVAQKRKISDGDKLAGRHGNKGVIGKILPVEDMPFLADGTPVDIILNTHGVPRRMNIGQILETHLGWCAHSGWKVDAAKGVPDWAARLPDELLEAQPNAIVSTPVFDGAQEAELQGLLSCTLPNRDGDVLVDADGKAMLFDGRSGEPFPYPVTVGYMYIMKLHHLVDDKIHARSTGPYSMITQQPLGGKAQFGGQRFGEMECWAMQAYGAAYTLQELLTIKSDDTVGRVKVYEAIVKGENIPEPGIPESFKVLLKELQSLCLNVEVLSSDGAAIELREGEDEDLERAAANLGINLSRNESASVEDLA	68.69	gnl|BL_ORD_ID|1957|hsp_num:0	1237			1092	3513	rifampin; rifaximin; rifabutin; rifapentine
BGC0000615.1|TP-1161_2 # 2453 # 6331 # 1 # ID=1_2;partial=00;start_type=GTG;rbs_motif=AGAG;rbs_spacer=15bp;gc_cont=0.658	BGC0000615.1|TP-1161_2 	2453	6331	+	Loose	850	29.261	OprM	29.41	3000379	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; monobactam; aminoglycoside antibiotic; carbapenem; cephalosporin; cephamycin; penam; tetracycline antibiotic; peptide antibiotic; aminocoumarin antibiotic; diaminopyrimidine antibiotic; sulfonamide antibiotic; phenicol antibiotic; penem; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGCTCGACGTCAACTTCTTCGACGAGCTGCGTATCGGTCTCGCCACGGCCGACGACATCCGCCAGTGGTCGCACGGCGAGGTCAAGAAGCCCGAGACCATCAACTACCGAACCCTCAAGCCCGAGAAGGACGGACTCTTCTGCGAGAAGATCTTCGGCCCGACCCGGGACTGGGAGTGCTACTGCGGTAAGTACAAGCGTGTCCGCTTCAAGGGCATCATCTGTGAGCGCTGCGGCGTCGAGGTGACCCGTGCCAAGGTGCGCCGTGAGCGGATGGGCCACATCGAGCTGGCCGCTCCCGTCACGCACATCTGGTACTTCAAGGGTGTGCCCTCTCGCCTGGGCTACCTGCTGGACCTGGCGCCCAAGGACCTCGAGAAGATCATCTACTTCGCGGCCTACATGGTCACGTGGGTGGACACCGAGGCCCGCGAGCGCGACCTCCAGTCGCTCGAGGCCCGGATCTCGGTCGAGAAGCAGCACCTGGAGCAGCGTCGCGACTCCACCATCGAGGAGCGCCACCGCAAGCTCGAGGCCGACCTGGCCGAGCTCGAGGAGCAGGGTGCCAAGGGCGACGCGCGCCGCAAGGTGCGCGAGGGCGCGGAGCGCGAGATGCGTCAGCTCCGCGACCGTGCCCAGCGCGAGATCGACCGTCTCGACGAGGTCTGGAGCCGTTTCAAGAACCTCAAGGTCCAGGACCTCGAGGGCGACGAGATGCTCTACCGCGAGATGCGGGACCGCTTCGGGAAGTACTTCCGCGGTGGCATGGGCGCTCAGGCGATCCAGGACCGCCTCTCCAACTTCGAGCTGGAGGAGGAGGCCGAGAAGCTCCGCGAGACCATTCGCACCGGCAAGGGCCAGAAGAAGGCCCGCGCCCTGAAGCGTCTCAAGGTCGTCTCGGCGTTCCTCAACACCACCAACAGCCCCATGGGCATGGTGCTGGACTGCATCCCGGTCATCCCGCCGGACCTGCGTCCGATGGTGCAGCTGGACGGTGGCCGCTTCGCGACCTCCGACCTCAACGACCTGTACCGTCGCGTCATCAACCGGAACAACCGCCTCAAGCGGCTTCTGGACCTGGGCGCGCCCGAGATCATCGTCAACAACGAGAAGCGGATGCTCCAGGAGGCCGTCGACGCGCTGTTCGACAACGGCCGCCGCGGTCGCCCGGTCACCGGTCCCGGTAACCGTCCGCTCAAGTCGCTGTCCGACATGCTCAAGGGCAAGCAGGGTCGTTTCCGTCAGAACCTGCTCGGTAAGCGAGTCGACTACTCCGGCCGTTCGGTCATCGTCGTCGGCCCGCAGCTGAAGCTGCACCAGTGCGGTCTGCCCAAGCAGATGGCCCTGGAGCTGTTCAAGCCGTTCGTGATGAAGCGCCTGGTCGACCTGAACCACGCGCAGAACATCAAGAGCGCCAAGCGCATGGTCGAGCGGTCCCGCCCGGTCGTGTGGGACGTCCTCGAAGAGGTCATCACCGAGCACCCGGTTCTGCTCAACCGCGCCCCGACGCTGCACCGCCTGGGCATCCAGGCCTTCGAGCCGCAGCTGGTCGAGGGCAAGGCCATCCAGATCCACCCGCTCGTGTGCACCGCGTTCAACGCGGACTTCGACGGTGACCAGATGGCCGTGCACCTGCCGCTGTCCGCCGAGGCCCAGGCCGAGGCGCGGCTGCTGATGCTGGCCACCAACAACATCCTCAAGCCGTCCGACGGTAAGCCCGTGACCATGCCCACCCAGGACATGATCATCGGTCTGTACTACCTGACGACGGAGCGGGCCGGCGCCGCGGGCGAGGGTCGCGCGTTCCGCTCCCCGGCCGAGGCCATCATGGCCTACGACCTGGGAGACCTGGACCTGCAGGCGAAGATCCGTCTGCGGATCTCCGACGGCGCTCCGGCCCCCAAGGACTGGACCCCGCCGGAGGGTTGGCAGCAGGGCGACACCTACGTCCTGGAGACGACCCTGGGTCGGTACCTCTTCAACGAGGCCACCCCGGTCGACTACCCGTACGTCAACTTCCAGGTGGGCAAGAAGCAGGTCTCGGTCCTGGTCAACGACCTGGCCGAGAACTACCCGAAGGTCCAGGTCGCCACGACCCTGGACGCCCTCAAGGACGCCGGTTACCGCTGGGCCACCCGGTCCGGTCTGACCATCGGCATCGAGGACGTCGTCGCGCCTCCGCAGAAGGAGGAGATCCTCGGCAACTACGAGCGCAAGGCCGACAAGATCCAGCGCGAGTACGACCGTGGTCTGATCACCGACGACGAGCGCCGTCAGGAGCTCACCGAGGTGTGGACCCAGGCCACCGCCGAGGTCGCCAAGAACATGGAGGAGAACTTCCCCTCCGACAACCCGGTGTGGATGATGGTCCAGTCCGGTGCCCGTGGTAACCCGATGCAGGTGCGTCAGATCGCCGGTATCCGTGGTCTGGTCTCCAACACCAAGGGTGAGACGATCCCGCGCCCGATCAAGTCCTCCTACCGTGAGGGCCTGTCCGTGCTGGAGTACTTCATCTCCACGCACGGTCAGCGCAAGGGTCTGGCCGACACCGCCCTGCGTACCGCCGACTCGGGTTACCTGACCCGTCGTCTGGTGGACGTCGCGCAGGACGTCATCGTCCGCGAGATCGACTGTGGCACCGACCGTTCCCTCTGGCACGAGATCGGTGAGAAGAACGCCGCCGGTGTCGTGGTGCGCAAGCACAACGTCGAGAACACCGGTTTCGGCCGGACGATCTCCGAGGACGCGGTGGACGCCGACGGCAACGTCGTCCTGCCCGCCCTGTCCGACACCTCCGAGCAGAACATCGACAAGCTGGTCGCCGCCGGGATCACCCGCGTGCGCATCCGTTCGTCGCTGACCTGTGAGGCGAAGATCGGTGTCTGCACCACCTGCTACGGTCGCTCCATGGCGACCGGTAAGCCGGTGGACGTCGGTGAGGCGATCGGTATCATCGCGGCCCAGTCCATCGGTGAGCCCGGTACCCAGCTGACCATGCGTACCTTCCACATGGGTGGTTCGGCCGGTCAGGACATCACCCACGGTCTGCCCCGTGTCCAGGAGCTCTTCGAGGCCCGCATCCCCAAGGGTGTGGCCCCGATCTCCGAGATGGAGGGCCGGATCCGGATCGACGACACCGAGAAGAGCCGCAAGATCGTCGTCATCCCGGACGACGGCACCGACGAGATCGCCTACCCGGTCCCGATGCGTGCCCAGCTCCTGGTGAGCGACGGCGACCACGTCAAGGTCGGTCAGCAGCTCATCCAGGGTGCGATCAACCCGCACGAGGTTCTTCGTATCCAGGGCCCGCGCGCGGTGCAGCAGCACCTCGTGTCGGAGGTCCAGGAGGTGTACAAGTCGCAGGGTGTGTCCATCCACGACAAGCACATCGAGATCATCGTTCGCCAGATGCTCAAGCGAGTGAACATCCTGGAGTCCGGTGACACCGAGCTGCTGCCCGGTGAGATGGTCGAGCGGCCCAAGTTCGAGCGGATCAACCGACGCGTGGTGTCCGAAGGCGGCCAGCCCGCCGCCGGACGTCCGGTCCTGCTGGGTATCACCAAGGCCTCGCTGGCCACGGAGTCCTGGCTGTCGGCGGCCTCCTTCCAGGAGACCACCAGGGTCCTCACCGAGAACGCGATCCACGGCAAGAGCGATCCTCTGCTCGGCCTCAAGGAGAACGTCATCATCGGTAAGCTCATCCCGGCCGGTACGGGTATTCCTCAGTACCGCAACGTTCGGGTCGAGCCGACCGAGGAGGCCAAGGCCTCGATGTACTCGGTCTCCGGGTACGAGGAGCCGAGTGAGTACACCTTCGGTCAGGGTTCGGGCGAGGCCGTGCCGCTGGAGGAGTACGACTTCGGGCCGTACAACCGGTAA	MLDVNFFDELRIGLATADDIRQWSHGEVKKPETINYRTLKPEKDGLFCEKIFGPTRDWECYCGKYKRVRFKGIICERCGVEVTRAKVRRERMGHIELAAPVTHIWYFKGVPSRLGYLLDLAPKDLEKIIYFAAYMVTWVDTEARERDLQSLEARISVEKQHLEQRRDSTIEERHRKLEADLAELEEQGAKGDARRKVREGAEREMRQLRDRAQREIDRLDEVWSRFKNLKVQDLEGDEMLYREMRDRFGKYFRGGMGAQAIQDRLSNFELEEEAEKLRETIRTGKGQKKARALKRLKVVSAFLNTTNSPMGMVLDCIPVIPPDLRPMVQLDGGRFATSDLNDLYRRVINRNNRLKRLLDLGAPEIIVNNEKRMLQEAVDALFDNGRRGRPVTGPGNRPLKSLSDMLKGKQGRFRQNLLGKRVDYSGRSVIVVGPQLKLHQCGLPKQMALELFKPFVMKRLVDLNHAQNIKSAKRMVERSRPVVWDVLEEVITEHPVLLNRAPTLHRLGIQAFEPQLVEGKAIQIHPLVCTAFNADFDGDQMAVHLPLSAEAQAEARLLMLATNNILKPSDGKPVTMPTQDMIIGLYYLTTERAGAAGEGRAFRSPAEAIMAYDLGDLDLQAKIRLRISDGAPAPKDWTPPEGWQQGDTYVLETTLGRYLFNEATPVDYPYVNFQVGKKQVSVLVNDLAENYPKVQVATTLDALKDAGYRWATRSGLTIGIEDVVAPPQKEEILGNYERKADKIQREYDRGLITDDERRQELTEVWTQATAEVAKNMEENFPSDNPVWMMVQSGARGNPMQVRQIAGIRGLVSNTKGETIPRPIKSSYREGLSVLEYFISTHGQRKGLADTALRTADSGYLTRRLVDVAQDVIVREIDCGTDRSLWHEIGEKNAAGVVVRKHNVENTGFGRTISEDAVDADGNVVLPALSDTSEQNIDKLVAAGITRVRIRSSLTCEAKIGVCTTCYGRSMATGKPVDVGEAIGIIAAQSIGEPGTQLTMRTFHMGGSAGQDITHGLPRVQELFEARIPKGVAPISEMEGRIRIDDTEKSRKIVVIPDDGTDEIAYPVPMRAQLLVSDGDHVKVGQQLIQGAINPHEVLRIQGPRAVQQHLVSEVQEVYKSQGVSIHDKHIEIIVRQMLKRVNILESGDTELLPGEMVERPKFERINRRVVSEGGQPAAGRPVLLGITKASLATESWLSAASFQETTRVLTENAIHGKSDPLLGLKENVIIGKLIPAGTGIPQYRNVRVEPTEEAKASMYSVSGYEEPSEYTFGQGSGEAVPLEEYDFGPYNR	MKRSFLSLAVAAVVLSGCSLIPDYQRPEAPVAAAYPQGQAYGQNTGAAAVPAADIGWREFFRDPQLQQLIGVALENNRDLRVAALNVEAFRAQYRIQRADLFPRIGVDGSGTRQRLPGDLSTTGSPAISSQYGVTLGTTAWELDLFGRLRSLRDQALEQYLATEQAQRSAQTTLVASVATAYLTLKADQAQLQLTKDTLGTYQKSFDLTQRSYDVGVASALDLRQAQTAVEGARATLAQYTRLVAQDQNALVLLLGSGIPANLPQGLGLDQTLLTEVPAGLPSDLLQRRPDILEAEHQLMAANASIGAARAAFFPSISLTANAGTMSRQLSGLFDAGSGSWLFQPSINLPIFTAGSLRASLDYAKIQKDINVAQYEKAIQTAFQEVADGLAARGTFTEQLQAQRDLVKASDEYYQLADKRYRTGVDNYLTLLDAQRSLFTAQQQLITDRLNQLTSEVNLYKALGGGWNQQTVTQQQTAKKEDPQA	266.39	gnl|BL_ORD_ID|2355|hsp_num:0	1305			585	786	erythromycin; amikacin; gentamicin C; ciprofloxacin; acriflavine; tetracycline; tobramycin; ceftazidime; ceftriaxone; meropenem; novobiocin; azithromycin; trimethoprim; sulfamethoxazole; chloramphenicol; thiamphenicol; aztreonam; colistin A; colistin B; ampicillin; nalidixic acid; norfloxacin; ofloxacin; panipenem; ticarcillin; trimethoprim-sulfamethoxazole; gentamicin
BGC0000615.1|TP-1161_4 # 10099 # 11352 # 1 # ID=1_4;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.605	BGC0000615.1|TP-1161_4 	10099	11352	+	Loose	1900	26.1794	MexK	26.67	3003693	protein homolog model	n/a	n/a	macrolide antibiotic; tetracycline antibiotic; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGCACCACGACCGGTTGTGCCTGCAGTTCTTCCTCGTCGTCCACCTGATTCTAGGTGTACCTGAGTTGCTGTTGGGTGTGTGGATTGCGCACCCAACAGCATCTTCGGGTCTTTTGAATGACTGGCATGATCATATATTCCGGGTCACCAGGAGTCCTTTAGTGCATTTTCTCGTGACCATTCCTATGTCCAAATACGACCTATCGGTCGCGGACCGGTACCGCTCTATGGTCTCGGAGCTCTTCTCCCGCGGTGGCCGGCTCCCCATCGGTGACCACTACTTCCTTCGGACCTGGGACCAGCGGACAGCGGGCGAGTGTGTCCAGGCGGTCATCGAAGTCGAGGACGCCGAGGCCCCGGGGGTTCTCGATGTGGTCAACGGGGTGGCCAGGGAGAACGGTTTCGAGGCGGACGTCCGGGAGACTCCGCCGGCAGAGGTGCCTTCCCCGCTCTGGAACGTCGGGTTCGCTGGGATCTCCTTCGACCGTGTCTCCAAGGCGCTTTACCGGGACGCCTCACCTCTGGCATCCGAGTTCGCCGGGGCGGCACGGGAGAGCGTGGGGGGCGCGTACCGCCTCGCGCTACGCCTCATGGCCGAGCATGACAAGGCCACCCTGGTTGGTTCCGAACAGCGCGGGGTCAGTCCGCTCGGTTTCGGTGATCTTCTTTCCACGCGGCTGTTGAGCTTTCGCTCGCACTATGAGGGTATGGCCGCCAGGGTGAGGGACCGGGAGTCCTTCGAGGGGCGTTGCGAGAAGTACTACGAGGATTTCGGGCACTATGCCAGGGGGCTGGTCTCCTCCTGTATGGAAAGTGAAAATCCTACCGATGATCCTCATATGCGGCAGTGGGCATTGAACATATCCGAGACCACGAAGCCGCTGCGTGAGGAAGTTCGCGAAGGTCGAATCGTCAATGTCGGCCTCACGCTCGACGATCTTAACCGTGATCGTGAAACCCTTCTTTCGCCGGCCGGTTTCCACGCTTTCGGTGCTGATTCCGAGGCTTTTCAGTACCTCATGAACAGCGATCCAGATTTCATGGCCTTTCGAATCCAGGCCGGCCTTCTCTATAGCTGCCTGCACACGATCGGTTTCAGTCTGCCGGAGCGCTTCGTGCTCTGTTATATCCTCGGGCGCGCCAATGAGGACGTGTCCGGTAAATCCGCGAACGAACTCCAGGAGCGGCTGATGTCCGTCGCGGAGGGGATGTACGCACGGACCGACCCGGCCCGGGAGGGACAGTGGTCCTGA	MHHDRLCLQFFLVVHLILGVPELLLGVWIAHPTASSGLLNDWHDHIFRVTRSPLVHFLVTIPMSKYDLSVADRYRSMVSELFSRGGRLPIGDHYFLRTWDQRTAGECVQAVIEVEDAEAPGVLDVVNGVARENGFEADVRETPPAEVPSPLWNVGFAGISFDRVSKALYRDASPLASEFAGAARESVGGAYRLALRLMAEHDKATLVGSEQRGVSPLGFGDLLSTRLLSFRSHYEGMAARVRDRESFEGRCEKYYEDFGHYARGLVSSCMESENPTDDPHMRQWALNISETTKPLREEVREGRIVNVGLTLDDLNRDRETLLSPAGFHAFGADSEAFQYLMNSDPDFMAFRIQAGLLYSCLHTIGFSLPERFVLCYILGRANEDVSGKSANELQERLMSVAEGMYARTDPAREGQWS	MSFNLSAWALQNRQIVLYLMILLGAVGALSYSKLGQSEDPPFTFKAMVVQTNWPGASAEEVARQVTERIEKKLMETGDYDRIVSFSRPGVSQVTFMAREDIHSSEIPELWYQIRKKISDIRATLPQSIQGPFFNDEFGTTYGNIYALTGKGFDYAVMKDYADRLQLQLQRIRNVGKVELIGLQDEKIWIDLSNTKLATLGLPLAAVQKALEEQNAVASSGFFETASDRVQLRVSGRFDSVEEIRDFPIRVGDRTFRIGDVAEVRRGFNDPPAPRMRFMGEDAIGLAVAMKPGGDILVLGKALETEFARLQQSLPAGLELRKVSDQPAAVRTGVGEFIRVLAEALVIVLLVSFFSLGLRTGLVVALSIPLVLAMTFAAMHYFGIGLHKISLGALVLALGLLVDDAIIAVEMMAVKMEQGYDRLKAASFAWTSTAFPMLTGTLITAAGFLPIATAQSGTGEYTRSLFQVVTIALVVSWFAAVVFVPYLGAKLLPDLARLHAQKHGGSADGYDPYATAFYQRFRRLVEWCVRYRKTVIVLTLAAFVGALLLFRLVPQQFFPPSARLELLLDIKLAEGASLRSTGEEVQRLEKMLQGHDGIDNYVAYVGTGSPRFYLPLDQQLPAASFAQVVVLAKDLESREALRKWLIERMNEDFPHLRSRISRLENGPPVGYPVQFRVSGEDIPQVRELARKVADKMRENPHVVNVHLDWEEPSKVVYLSIDQERARALGVSTASLSQFLQSALTGSHVSFFREDNELIEILLRGTEQERRDLSLLPSLAVPTENGRSVALSQIATLEYGFEEGIIWHRNRLPTVTVRADIYDDSLPATLVAQIAPTLEPIRAELPDGYLLEVGGTVEDAAKGQSSVNAGVPLFIVVVLSLLMVQLRSFSRMAMVFLTAPLGLIGVTLFLLLFRQPFGFVAMLGTIALAGMIMRNSVILVDQIEQDISHGLDRWHAIIEATVRRFRPIVLTALAAVLAMIPLSRSVFFGPMAVAIMGGLIVATVLTLLFLPALYAAWFRVKKDEARA	40.68	gnl|BL_ORD_ID|2016|hsp_num:0	2206			2460	2595	erythromycin; tetracycline; triclosan
BGC0000615.1|TP-1161_5 # 11402 # 12748 # 1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=GAGA;rbs_spacer=5bp;gc_cont=0.684	BGC0000615.1|TP-1161_5 	11402	12748	+	Loose	1900	31.5722	TriC	31.37	3003681	protein homolog model	n/a	n/a	disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAATCCCGACCAGGCGACGATCGACCCCCTTACGGAGCTGCGCCGTGTCACGGCCCTGCTCTCCCCTTACGGGCTGGTGTCCGGGAGCCTCGCGCTGCCCCGACCCGAGGGAGAACCCGGCTTCGAGGTCTACGCCGCGAGCCTCGGTGATCCCTCGAAGGTCTTGGACAACCTCCGTGGCTGGAACCGCGGGGCCGACATGGGCAACATGAACGGTGCGGGCAGCGCTCTCACCCCCGAACGCGCTCGACTCGTCTCGCTCGCCGAGTCCCTCGAACGCTACTCGACGTGTGCCTGGGACGAGGGCGGACTGACGGTCGCGTCCGAGTCCGAGCTCGACGTGGAATACGTGTCCCCGTCTCGCTGGCCCCGCTGCTCCGCCGAGGAACTACGGAGCGAGCACTGCGGCCTGCGCGAGTACGACCCGACCCTGCCGATCCGATGGGTACGCGGATGGTCGCTCACTAGGCGGCGCGAGGTCCTCGTCCCGGCTCAGGCGGTGTACATGCACATGCCCGAGCGCTCGCCGTCGGAGCGCTTCACCCGAGGGATCACGACCGGATCGGCGGTGCACACCGACCTCAGATCCGCCGTCCTGGGTGGACTGCTCGAAGTGGTCGAACGCGATTCGATCTCCCTGGTGTGGCTGCGGCGACTGCGTCTCCCGGAGTTGTCGGTGGATGCCGGGCTCATGGATCCCATCGACGGCGATCATGTTCGGGAGGGGGCCTCCGGCCCTTTCGACGTCCGGTTCTTCGACGCCACGACGGACTTCGGTGTCCCGGTCGTCTACGCGTTGCAGCTGTCCGACGTCGACGAAAGGATCGCGCAGGTCGTGTGCGCCACGTGTGAGAGCGATCCGGGAAGGGCGGTGGCCAAGATCTACCGGGAGCTGGCCTCCCTGCGGGTGGCGGTGCGTGCTCACGCCGCCGGAAACCCCGTGGTCAGGCCCGAGCCCGGAGAGGTGAGTGTGGCCGGAGGCGCCGCCTATAACGCCGACATCTCGCGCCGCCGCGTGTTCGACTTCCTCCTGCGGGGGGAGCGGGAGAGACGCCATATCGCCACGATGCCAGGGGCCTTGGACAAGGACGATCCGCTCGGTGACGCGGTCGAGCGCTTGGCCGACCGGGGCGCCGAGGTTCTCGCTGTGGACATCACCACCGACGAGGCCAGACAGGTCGGGATGCACGCGGTCAAGGTGGTGGTGCCCGAGGCCATGCCGCTCTCCTTCATCCACGCCGAGCGCTACCTGGCCACCGAGCGACTGCGCACGGCGCCTCGGGCCATGGGAGTCGAGAGCCACGGTCCGGAGTTCGTCAATCCCGAGCCACAGCCATTCGCGTAA	MNPDQATIDPLTELRRVTALLSPYGLVSGSLALPRPEGEPGFEVYAASLGDPSKVLDNLRGWNRGADMGNMNGAGSALTPERARLVSLAESLERYSTCAWDEGGLTVASESELDVEYVSPSRWPRCSAEELRSEHCGLREYDPTLPIRWVRGWSLTRRREVLVPAQAVYMHMPERSPSERFTRGITTGSAVHTDLRSAVLGGLLEVVERDSISLVWLRRLRLPELSVDAGLMDPIDGDHVREGASGPFDVRFFDATTDFGVPVVYALQLSDVDERIAQVVCATCESDPGRAVAKIYRELASLRVAVRAHAAGNPVVRPEPGEVSVAGGAAYNADISRRRVFDFLLRGERERRHIATMPGALDKDDPLGDAVERLADRGAEVLAVDITTDEARQVGMHAVKVVVPEAMPLSFIHAERYLATERLRTAPRAMGVESHGPEFVNPEPQPFA	MKGGFNLSDWALRHQSLVWYLMAVSLVMGVFSYLNLGREEDPSFAIKTMVIQTRWPGATVDDTLEQVTDRIEKKLEELDSLDYVKSYTRPGESTVFVYLKDTTKAGDIPDIWYQVRKKISDIQGEFPQGIQGPGFNDEFGDVFGSVYAFTADGLDFRQLRDYVEKVRLDIRSVKDLGKVQMIGAQNEVIYLNFSTRKLAALGLDQRQVVQSLQAQNAVTPSGVVEAGPERISVRTSGNFRSEKDLQAVNLRVNDRFYRLSDLASISRDFVDPPTSLFRYKGEPAIGLAVAMKEGGNILEFGEALNARMQEITGELPVGVGVHQVSNQAQVVKKAVGGFTRALFEAVVIVLIVSFVSLGLRAGLVVACSIPLVLAMVFVFMEYTDITMQRVSLGALIIALGLLVDDAMITVEMMITRLELGDSLHDSATYAYTSTAFPMLTGTLVTVAGFVPIGLNASSAGEYTFTLFAVIAVALLLSWIVAVLFAPVIAVHILPKTLKHKSEQKKGRIAERFDSLLHLAMRRRWTTIFLTALLFGVSLFLMKFVQHQFFPSSDRPELLVDLNLPQNSSIHETRAVMDRLEATLKDDEDIDHWSAYVGEGAIRFYLPLDQQLQNNFYGQLVIVTKDLEARERVAARLRDRLRKDYVGISTYVQPLEMGPPVGRPIQYRVSGPQIDKVREYAMGLAGVLDGNPNIGDIVYDWNEPGKMLKIDIAQDKARQLGLSSEDVAQIMNSVVTGSAVTQVRDDIYLVNVIGRAEDSERGSLETLESLQIVTPSGTSIPLKAFAKVSYELEQPLVWRRDRKPTITVKASLRGEIQPTDLVARLAPEVKRFADGLPANYRIEVGGTVEESGKAEGPIAKVVPLMLFLMATFLMIQLQSVQKLFLVASVAPLGLIGVVAALLPTGTPMGFVAILGILALIGIIIRNSVILVTQIDAFEKDGKTPWEAVLEATHHRTRPILLTAAAASLGMIPIAREVFWGPMAYAMIGGIVAATLLTLIFLPALYVAWYRIPEPGR	44.14	gnl|BL_ORD_ID|2004|hsp_num:0	2194			2019	2169	triclosan
BGC0000615.1|TP-1161_6 # 12764 # 13378 # 1 # ID=1_6;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.670	BGC0000615.1|TP-1161_6 	12764	13378	+	Loose	800	26.5646	mel	32.56	3000616	protein homolog model	n/a	n/a	macrolide antibiotic; streptogramin antibiotic	antibiotic target protection	msr-type ABC-F protein	GTGAACACTTCTATGTCCGATGACCGCTGCTTCTACGTGCTCAGCGGAGAGTTCGGGCGACAGTACGCCGACACCCGCGGAATCCCGTGTGGGCGCAGGTTGACGGTGTCGTCTCTGCCCGAGGCGGCCGATCTGCCGGAGGCGGAGGTCTTGGTCGGCATCCATTCCGGCAGGGATACCGCGTTGCGTGACGCCATCGACCGGGTCGGGTTCGAGCGCGGTACGGCCACGGTCGGGGTCGAACTCCTGCCAGGGAGGATCACTTGTGGTCCCGTCGTGGTTCCGGGGAGGACTGCCTGTTATGCGTGCTATCTGCGCCGCATCGAGCAGCACCGGGGTTCCCCCGGCCTCCACGACGTGGAGGCGTCGTCCCGGGGAATAGCCGAGGGGTTCGCCCCCGCCCACCTGTCCATCGTCGAGGGGATGATCGCCCTCGCGTGTGGTGAGATCCGTGACGGGCTTCGGGGCCTGGGCGGCACAGTGCGCTCCTTCAACCTCGTGACGGGTGCATTCTCCAGCTCGCAGACCGTGGCAGTGGATCGCTGCCCGAGGTGCGGCCCCCGCTTTCGCGATGACCGGAGCGACACTGTGTCCGCTCTCAGAGAACTGCCCTGA	MNTSMSDDRCFYVLSGEFGRQYADTRGIPCGRRLTVSSLPEAADLPEAEVLVGIHSGRDTALRDAIDRVGFERGTATVGVELLPGRITCGPVVVPGRTACYACYLRRIEQHRGSPGLHDVEASSRGIAEGFAPAHLSIVEGMIALACGEIRDGLRGLGGTVRSFNLVTGAFSSSQTVAVDRCPRCGPRFRDDRSDTVSALRELP	MEKYNNWKLKFYTIWAGQAVSLITSAILQMAIIFYLTEKTGSAMVLSMASLLGFLPYAVFGPAIGVLVDRHDRKKIMIGADLIIAAAGSVLTIVAFYMELPVWMVMIVLFIRSIGTAFHTPALNAVTPLLVPEEQLTKCAGYSQSLQSISYIVSPAVAALLYSVWELNAIIAIDVLGAVIASITVAIVRIPKLGDRVQSLDPNFIREMQEGMAVLRQNKGLFALLLVGTLYMFVYMPINALFPLISMDYFNGTPVHISITEISFASGMLIGGLLLGLFGNYQKRILLITASIFMMGISLTISGLLPQSGFFIFVVCCAIMGLSVPFYSGVQTALFQEKIKPEYLGRVFSLTGSIMSLAMPIGLILSALFADRIGVNHWFLLSGTLIICIAIVCPMINEIRKLDLK	50.37	gnl|BL_ORD_ID|1130|hsp_num:0	1231			522	651	erythromycin; telithromycin
BGC0000615.1|TP-1161_8 # 15020 # 15721 # 1 # ID=1_8;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.688	BGC0000615.1|TP-1161_8 	15020	15721	+	Loose	750	25.7942	tet(39)	31.25	3000566	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	GTGAGATCTGACCAACGGCCCCTGCGCTCCGTCTTGGACGGGTTCGAGTCCAGGAAGCCCACATCCGACGGCCGGGCGGCGCTGCGGGTGCCCGAGCCCTTCGAGGGAGCGGAGCCCGTCGACATCGACCTCTCGGTACACGACCTCGAGTCGAGGCGTGACCTGTTCGCGACGCTTACCGCGCGGCGGTCCATGCTCCGGTACTCGCGGGCCCCTGTCCGCACCGAGCTCGTGATCGGACTGCTCCAGGAGGCACTGGCCCGGGACACCAGCACCTGGTCGCTCGATGAGGAGGCCGGGCCGCTCGAGGGGTTCGTCTTCGCCCTGCGCAGCGAGGGCCTCCCCACGGGCGTGTACCGGGTCACCGCAAGCGGCTGTTCACGGGTGGCGCCGGTGGAGGTCATCGGTGAACCGGAGGAACTGGGGGTTCAGCGCGAGTTCGTCACCGGAGGCGGAGTCATCAGTGTCTTCGGAGACCTCGACCGGGCGGACTCGTGGGCGGGCTCCCACGGCTACCGGATCTGCCTGGTCCGGGCCGCCATGGTCGCCTACGACTTCCACATGCGACTCCAGTCCACCGGCCTGGTCGGAACGATCTTCGGTGGCTTCATAGCCGCGTCCGTACGCGATACGGCCAAGAGTGACGGGGTGACCCGCCAACCGCTCCTGTCCAGCACGTACGCGCATCCCATCGGCCTGTGA	MRSDQRPLRSVLDGFESRKPTSDGRAALRVPEPFEGAEPVDIDLSVHDLESRRDLFATLTARRSMLRYSRAPVRTELVIGLLQEALARDTSTWSLDEEAGPLEGFVFALRSEGLPTGVYRVTASGCSRVAPVEVIGEPEELGVQREFVTGGGVISVFGDLDRADSWAGSHGYRICLVRAAMVAYDFHMRLQSTGLVGTIFGGFIAASVRDTAKSDGVTRQPLLSSTYAHPIGL	MKKSLSVILITIFLDAVGIGLIMPILPELLRSLAGAEAGGVHYGALLAVYALMQFIFAPILGALSDRFGRRPVLIISIAGATADYLLMAAAPSLLWLYIGRIFAGITGANMAVATAYVSDITPAHERAKRFGLLGAVFGIGFIAGPVIGGVLGEWNLHAPFFAAAFMNGINLIMTAVLLKESKHSNKMTEKVQEQSILKKLSYLITQPNMAPLLGIFLIITLVSQVPATLWVIYGQDRYGWSIFIAGVSLASYGICHSIAQAFAIAPMVKRFGEKNTLLCGIACDAIGLLLLSIAVEEWVPFALLPLFALGGVAVPALQAMMSRGISDERQGELQGLLSSFNSLGAIIGPVLVTSLYFMTQASAPGMVWALAAILYVITLPLLLKYRLNKYSGVP	58.99	gnl|BL_ORD_ID|1037|hsp_num:0	1092			372	516	tetracycline
BGC0000615.1|TP-1161_9 # 15813 # 17627 # 1 # ID=1_9;partial=00;start_type=TTG;rbs_motif=GAGA;rbs_spacer=9bp;gc_cont=0.703	BGC0000615.1|TP-1161_9 	15813	17627	+	Loose	1000	27.335	tva(A)	29.73	3004730	protein homolog model	n/a	n/a	pleuromutilin antibiotic	antibiotic target protection	Miscellaneous ABC-F subfamily ATP-binding cassette ribosomal protection proteins	TTGAGCCAGAGCACTGAGGACACCGGCCACCGGGGGTTCGTCCTGGCGCGTTCCGACGTGGAGGTCGCCGGGACGGACGAAGGTGCGTGGATCGGCATCTCCGACTCCTCGTTCACGGTGCGGGGGAACGGAGCCCATCGCCTCATTCGCGACCTGGTCGCTGGATGCGACGGCAGGGCCACGGTCCAGGACGTCCTGGACCGTGGCCCCGGAGCAGGACGCCCGGTGGCGGACACACTGCTCAAGGCGTTGGTCCGGCGCCGCTACGTGGTCCTGCTCGACCAGCCGTTGGGTGGAGCCGGGGCCGGGTCGGCGCCTGATCCCCTGATCAGGCAGTTCGCGCACTGGACCGAGGACTCCTCCGCGGCGGTGGCACGACTGTCCGGAAAGAGCCTCCGGCTGGTCGGAGAGCCCGGGTGGTTGGAACGGGTGCGCTCGGAGCTCGACGGCCTGGTGCCCCCCGGTCTCCGAGTGGAGGACCTTCCGGTCACCCCCGGTCGAACGCGCGCCCCTCTCCTAGACACGTATCCGGGAGAACCGGCGTCCGCGTCGTGGCAGGCGGGCGATGTCGTCGCGCTTCAAGCCGACGCGTTCTCCGCCGACGAACTGGCCCGGGAACAGAAGAGCCTGTGGAACCACGGGGCGCCGCACTGCGTGGCCGGGCGGATAGGTTCCCGGTACTGGCTGCTCTGGTCGCGCGACGGTGGGACCGGCTGCTGGCGGTGTCTTCGAAGCCTGGCCCTGGCGGCCGAGGTGGCGGCCCCGGACACCGGTGTCGGAGCGCTCACGGACGTAGCCGGCCATGTGAGTGTGGCGAACCTGGTCCGGTCTCTGCTCGCCCGCGCTGCAGGGATCGACGACGCATTCGGGACCGCTGACGCGCTCTCGGCGGACGTACACGAACTGTCGGTGCGCACGCACACGGTCGTGCGGCGGCCCGGTTGTGCCTGTCGCTGCACGGAGTCACGGAAACCAAGACACGGCTCCGGCCCTGCCGAGGCGGTCATTCGCCGGAACTTCTATGCCTCCGACGACTCCGACCGCTCCGACGAGCACCACGCGGAGATCATGGGCACCCTCGCCTCTTGGACGGACGAACGCGTCGGCCCGTTCCTGGAAATCGATCGCGACACCCTCCCACAGGTTCCGTTGGGCGCCGCCTACGCGCGGGCCCTGAACCTTGTTGACGAACACGGGGGGATCGCAGCCACGGTTCGCACGCTCTCCTCCCGAGAGGCCTACTACCAGGCGGCACTCAACGTGCTCGAAGTCACCTCGAGGCACGGTGCCGGGGAGACCGACCCGGCGCGGTACACGGGCGCGGGCTGGACACATGGCGAGGCCACCTACCGCGCACTTCTGCGCTCCCTGCCCGGCGCTCCCTCCGACCCGCGGACCATGGCTCCGCTCGACCTGGACGACTCGAGTGACGGTGAGTGCGCCCGGATGGCCCGGTACCTGGAACGGCGCCTCGGGAACCGGGGTATCGGCGGCACCTGGCTGGGCGAACACCTCGGAAACGGGCTCTGCCACGCGGCCCTGATCGCAGAGGGCGGGCCCGCCGTCAGCGGTTACGGAGCCTGCTACGGCGAGGCTGTGGCGATGGCTCTGCTGCGCACGGTCAACGACGGGGTCCTCGTACACGTCAACCCCCACCACACCACCTGGGGCGACTTCTGGACACAGGTCACGGCGCCCGTGGGTCTCGAGGACGTGTCCCTGCCGTTCGCCCAAGGCCCGGCCCGGATCGTCGGGTTCGTGCCAGAGTCCGGAGCCCGCCGACCCTACGATCTCGCGGAGGTGTCCGTCCCGTGA	MSQSTEDTGHRGFVLARSDVEVAGTDEGAWIGISDSSFTVRGNGAHRLIRDLVAGCDGRATVQDVLDRGPGAGRPVADTLLKALVRRRYVVLLDQPLGGAGAGSAPDPLIRQFAHWTEDSSAAVARLSGKSLRLVGEPGWLERVRSELDGLVPPGLRVEDLPVTPGRTRAPLLDTYPGEPASASWQAGDVVALQADAFSADELAREQKSLWNHGAPHCVAGRIGSRYWLLWSRDGGTGCWRCLRSLALAAEVAAPDTGVGALTDVAGHVSVANLVRSLLARAAGIDDAFGTADALSADVHELSVRTHTVVRRPGCACRCTESRKPRHGSGPAEAVIRRNFYASDDSDRSDEHHAEIMGTLASWTDERVGPFLEIDRDTLPQVPLGAAYARALNLVDEHGGIAATVRTLSSREAYYQAALNVLEVTSRHGAGETDPARYTGAGWTHGEATYRALLRSLPGAPSDPRTMAPLDLDDSSDGECARMARYLERRLGNRGIGGTWLGEHLGNGLCHAALIAEGGPAVSGYGACYGEAVAMALLRTVNDGVLVHVNPHHTTWGDFWTQVTAPVGLEDVSLPFAQGPARIVGFVPESGARRPYDLAEVSVP	MFIKFNKVSFSYDSSDNILNDVSFHIDNSCTAIVGENGCGKTTLAKLITGILKPNSGSIEYSNKNIITAYCDQECINLPDNAENLFYDDSSYSGYLTSIFKIDYNYLYRFDTLSFGERKRLQIASALYSNPDILVLDEPTNHIDIECKDILINVIKRLDCIVIIISHDIDFLDELVEKCIFIRNGNCKIRIGNYTQCRGYEKDEEDYNFSLYEESRKKAKILENRYKKLQNESDAKKSKCGSKRHIDKKDHDAKGKIDAARLAGKDSRLATKAKQAKSLYNNTVMEMESLYTKKREVMDMEFIGERYKGKFLFYLEAGETKINSIVLRHPELIVKKDSRIGIEGVNGAGKTSLLNYIIETMYDNSIDKEKIIYIPQDIDRESWNNTFNNIKALDHESLGFLMSFVNRLGSNAKSVINSLNHSPGEMRKIMLGMAVIKKPYIIMLDEPTNHLDIDSIERLEEALISFNCALIIVSHNRNFIKNAVNTLWSIKIEYNYSILDIKNTI	119.60	gnl|BL_ORD_ID|2257|hsp_num:0	3484			1236	1341	pleuromutilin
BGC0000615.1|TP-1161_11 # 19604 # 20413 # -1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.605	BGC0000615.1|TP-1161_11 	19604	20413	-	Loose	450	290.041	tsnR	55.26	3003060	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	non-erm 23S ribosomal RNA methyltransferase (A1067)	ATGGCCGAATTTGAAACAATTGATAATCCTTCCGATCCGGCAATCCGGAGGATTATCGACGTCACCAAGCCATCCAGGTCCAATATCAAGACCACGTTGATCGAGGACCCCGAGCCCCTCGTTCAGTCCATCAATGCCGGCGTCGAGTTCATTGAAATCTATTTCAGTGACGCCACTCCGGTGGATCCCAAGATCGCCGATCTCTGCGAGAAGAATCGAATCCCGATCAGACTCGTCGACTACACCGTCGTCAACAAGATCTTCAAGGGAGAGAGAAAGGCCAAGGCATTCGGCCTCGCGCGCGTTCCTCGTCCCGCGAAGTTCCACGACATCGAGAATCGCCCGGGGGACATCATCGTTCTCGACGGCGTGAAGATCGTCGGGAATATCGGCGCGATCGTGCGAACCTCGCTCGGGCTCGGCGCGGCCGGGATCGTCCTCATCGACAGTGATCTGACCAGCATCGCCGACCGGCGCCTCCTCCGAGCCAGCCGCGGTTACGTCTTCTCCCTCCCCATCGTTCTAACCGACCGCGAGAGTGCCGCCTCCTTCATCCGGGACAGCGGCGTCGAACTGGCGGTCCTGGACTCCCATGGTGAGACCCCCTTGAAGGAGATCGGCAACATCGACCGGAAGATGACCCTGCTCTTCGGGAGCGAGAAGGGCGGCCCTTCGGAGCGGCTCCGCGAGCTCGCCTCGACCACCGTCTCCATCCCGATGATCAGTTCGACCGAGTCGCTCAACGTCTCGGTCTCGGTCGGGGTCACCCTCCACCAGCGGGTGGAAAGGAACATCTCCCTCAGGCGATGA	MAEFETIDNPSDPAIRRIIDVTKPSRSNIKTTLIEDPEPLVQSINAGVEFIEIYFSDATPVDPKIADLCEKNRIPIRLVDYTVVNKIFKGERKAKAFGLARVPRPAKFHDIENRPGDIIVLDGVKIVGNIGAIVRTSLGLGAAGIVLIDSDLTSIADRRLLRASRGYVFSLPIVLTDRESAASFIRDSGVELAVLDSHGETPLKEIGNIDRKMTLLFGSEKGGPSERLRELASTTVSIPMISSTESLNVSVSVGVTLHQRVERNISLRR	MANLDVIVDRSDPAVQRIVDVTKHSRSVVRTVLIEDIEPLTQSIRAGVEFTEVYGLDTVPFPGDLLAACEKRGIRVRLLSAAVANQVFKTEKKPKVFGIAKVPPAGRFADLESLSGDVVLLDGVKIVGNIGAIVRTRSALGAAGIVLVDSGLGTIADRRLIRASRGYVFSLPIVLATRDEALAFFRDGGMRPVVFEADGKLSIGELDGIDERLVLVFGSEKTGPSGEFAGVATESVSIPMNPAAESLNVSVSAGIALHRRARRNLSRPRG	99.63	gnl|BL_ORD_ID|148|hsp_num:0	49			0	798	thiostrepton
BGC0000615.1|TP-1161_12 # 20475 # 21689 # -1 # ID=1_12;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.629	BGC0000615.1|TP-1161_12 	20475	21689	-	Loose	1900	26.9498	acrB	50.0	3000216	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGGCAATTTCCCGTCCGGCCATAGAGAACACGAAGAAGATCAAGGATATTTTCATGCAGGCGGACATTCACTGGATGGCGGGGACACGACTCCGAAGCGGGAGCGATTTTCTGACGCAGCTGAAGGAGGAGTTGATGCCTCTCCCTCAACCGACGCTCTTCGTTTCCGACCCCACCCCGGTACACTCCGACGCGGTTTTGAGCGACCTCCACACGCAGATTCCGGAAAAACTGTGTTTCTTCAGAAAGGCCCGCACCCCTTCATCGGAGGAGGTTCGGAACACCGCCGAGGAATGGCTCCGCCGGGGCATCGCGAGCGTGGTCGTCACGGGCGGAGGTTCGACCATCGACTTCGCCAAGGCGGTCGCCCATTGCATGGCCTATCCTTCGACATTCGACCAGGAGCCTTCAAGTGGGCTCGTGTTCAACACTTCGTGGTCGCCTCCGCACCTGCCGATGATCGCCGTCCCCACGACCATGGGAACCGGGAGCGAAGTCAACGGAAAGTCGGTCGTGGACTTCGCTGGCAAGAGACGCCTGGTCTTCCATTGGGGGATGTATCCGCAGTCCGCCATCATCCATGCCCCGTTCTTCCGAGGGATGCCCGAGGAGGTGCTGGTGGGCGGCGCTCTCGAAACCATGGCGCGGCTCGTCGTCCCGGTGGTCTCATCGGAGAGCCCGGTCAGGGTGGCCGACTCCCTCGCCGTCGCGCAGGTCCGGGCCCTGACCGAGGTCGTGAACCGGCTGTTGACCGACCCCGGCGACGAACAGGCCAGGTTCGACCTCGCGATGATCACGGTGACGAGCGTCCTCACCCTGCATCAGCTCGGCCGGAGCCAGTTCTCCTACTGGCTGTGGTACCTGGTCAACGAACTGAACAACTTCGATCTGACGAAACAGCAGTCCCTCGCGACGCTGATGCCGGTGTGGCTCGAGCTCGTCCGCGACGGCGAAATCCCCGGTAGGGAAGGACTGAGCCGAATGGAGGCGGAGCTCTCCCCGACCGCGCACTCAGCGAAGACGTCCCCTTCCGGGCTCACGGGCACACTGCTCGGTATGACCTCCCGCCTCACACCATCCCCCTCTACCGGGCTCAATGCCCGGACACTGACCGACTCCACCTGGCGGGACTGGGGTCAAGGGCTACGACAGGTGAACATCGGCGAACACCATGTCGAGCGCGTCTTCTCCGAACTCCTGTCCCCCGCCACCTGA	MAISRPAIENTKKIKDIFMQADIHWMAGTRLRSGSDFLTQLKEELMPLPQPTLFVSDPTPVHSDAVLSDLHTQIPEKLCFFRKARTPSSEEVRNTAEEWLRRGIASVVVTGGGSTIDFAKAVAHCMAYPSTFDQEPSSGLVFNTSWSPPHLPMIAVPTTMGTGSEVNGKSVVDFAGKRRLVFHWGMYPQSAIIHAPFFRGMPEEVLVGGALETMARLVVPVVSSESPVRVADSLAVAQVRALTEVVNRLLTDPGDEQARFDLAMITVTSVLTLHQLGRSQFSYWLWYLVNELNNFDLTKQQSLATLMPVWLELVRDGEIPGREGLSRMEAELSPTAHSAKTSPSGLTGTLLGMTSRLTPSPSTGLNARTLTDSTWRDWGQGLRQVNIGEHHVERVFSELLSPAT	MPNFFIDRPIFAWVIAIIIMLAGGLAILKLPVAQYPTIAPPAVTISASYPGADAKTVQDTVTQVIEQNMNGIDNLMYMSSNSDSTGTVQITLTFESGTDADIAQVQVQNKLQLAMPLLPQEVQQQGVSVEKSSSSFLMVVGVINTDGTMTQEDISDYVAANMKDAISRTSGVGDVQLFGSQYAMRIWMNPNELNKFQLTPVDVITAIKAQNAQVAAGQLGGTPPVKGQQLNASIIAQTRLTSTEEFGKILLKVNQDGSRVLLRDVAKIELGGENYDIIAEFNGQPASGLGIKLATGANALDTAAAIRAELAKMEPFFPSGLKIVYPYDTTPFVKISIHEVVKTLVEAIILVFLVMYLFLQNFRATLIPTIAVPVVLLGTFAVLAAFGFSINTLTMFGMVLAIGLLVDDAIVVVENVERVMAEEGLPPKEATRKSMGQIQGALVGIAMVLSAVFVPMAFFGGSTGAIYRQFSITIVSAMALSVLVALILTPALCATMLKPIAKGDHGEGKKGFFGWFNRMFEKSTHHYTDSVGGILRSTGRYLVLYLIIVVGMAYLFVRLPSSFLPDEDQGVFMTMVQLPAGATQERTQKVLNEVTHYYLTKEKNNVESVFAVNGFGFAGRGQNTGIAFVSLKDWADRPGEENKVEAITMRATRAFSQIKDAMVFAFNLPAIVELGTATGFDFELIDQAGLGHEKLTQARNQLLAEAAKHPDMLTSVRPNGLEDTPQFKIDIDQEKAQALGVSINDINTTLGAAWGGSYVNDFIDRGRVKKVYVMSEAKYRMLPDDIGDWYVRAADGQMVPFSAFSSSRWEYGSPRLERYNGLPSMEILGQAAPGKSTGEAMELMEQLASKLPTGVGYDWTGMSYQERLSGNQAPSLYAISLIVVFLCLAALYESWSIPFSVMLVVPLGVIGALLAATFRGLTNDVYFQVGLLTTIGLSAKNAILIVEFAKDLMDKEGKGLIEATLDAVRMRLRPILMTSLAFILGVMPLVISTGAGSGAQNAVGTGVMGGMVTATVLAIFFVPVFFVVVRRRFSRKNEDIEHSHTVDHH	38.51	gnl|BL_ORD_ID|1011|hsp_num:0	1104			525	597	tigecycline; tetracycline; rifampin; chloramphenicol; ampicillin; cefalotin; triclosan
BGC0000615.1|TP-1161_14 # 22269 # 25058 # 1 # ID=1_14;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.662	BGC0000615.1|TP-1161_14 	22269	25058	+	Loose	600	28.4906	BCL-1	34.48	3004749	protein homolog model	n/a	n/a	penam	antibiotic inactivation	BCL Beta-lactamase	GTGGCATGGGGTTCCGCTTTTCTTTTAAAGGGAAAGCGGAGCCCTCCCTTCCATGTGCTGACCGAGCGGTTTCTGACGGGGTGTTCGATGAGTGTAAATGTGAGCCCGTACGTTCTCTTTCGGAGGAATAGGATTCCTGTTTCGGAGGTCGCTTGCATCAATTTTGGCGATTCCTGGTCGGGGATCGATGGAGCGAACATCCTGCGTGCGGAAGCGGAGAAGTTCGCGGACTCCCTCTCCTCTCTCCTGGCCGGAATCGTGCCGGAGACGGAGAAACCGGTACGATCGAAGATCGTGCAGTTGAGAAGGGACGTGCACAACGGTCGGCATGAGCGCGTGGTGTCGAGGGCCTCGGAACTCCGCCCTTACCTGGGAGAACGGATCTTCGGGGAAATCCAGGACTGGGTCGAGGCCAGTGAGGGCGCGTACCACCGTGAGAAGGAGGCCCGGGAGGCCTTCGCTCGGGAACAGGAGGAGGCCAGGGCGGCCTTCACCTCGTTGTTCGGGTACGAGGCGATCGGCAAGAGCATCCAGCTCTCGGGCGGCCAGCTTTACCAGAGCCTGCTCAACTATGTCGAACAGGGACCCGGCGCCTTCAAACCGAGCAAGGTCCGCAACTTCGAGTCGACACTGGTCAACTACGTCTACCGGGCGAGCCTGAAGCCCTCCCCCTTCGGCTGGTTCACGGAGGTCGGGGCGTTCCCGGCCGACCTCGGCCAAGGGAACCGGGCAGACGGCGAGGACGAGGGCACCGGCTCCCCGGTCGGACCGGCGGCCGCGGCCACCGTCGCGGACGGGGACGCGTCGGTCGCCAAGCTGAACGTCTTCCTCATGAACTGGATCGTGGGAGCTCTGACGGGGGTGCCGGGAGGCTGGGGGGTCGGCGTCTTCCTCCTGAACCCCACGGTCAGAGTCGACGGGGAGCAGATCGAGTTCAGCGGTACCTCCAACGAGTCCTTCCTCCAAGGGCGCATCCACGGCGAGATGGTGCGGATCAAACGCGACCGCGTCGTCGAGTGCCTACTGGAACTGCTCTCGGGCGGGCCCCGGGCCGCGGCCGATGTGGCCGGCGCTCTGGCCGACGCCACGGGAGACGAAGGCTACGCGCGGCGTATTCTGACGGCCTTGATGCGGGTCGGGCTGGTGTTCTTCCGGGTGGATATCGACGACCAGGACGCGGAGTACTCGCGCAAGTTCGAGGAACTCCTCCGCGAGGGGGGAACTCCTCAGCTCGCCCGATTGGCGGACGAGTTCTCCGCCCTGCGCGAGGTCGAGGCGGGGCTCCCCGGCGCGACCATCCCCGAGCGCGAGGCCCTCCTGCTCTCGGCGCAGCGGTCGGTTTCCGCCATCGCGGAGGCCTGCGGCACGACCCTCCCACCGGAGGTGATGATGCGGTCACCCGTCTACGAGGATGTGCCGACCCGGACGCGCCCGCGGACATGGAGTCCCGAGACCGTCACCGGGGGGCTCGACGCGTTGGAGGGCCTGTGGCGCTTCTCCTCCCTCTTGGAGCAGGGGCAGACGAAGCGGCTGGCGCTGTACGCCTTCGCCGTCCAGAGCTTCGGAGACCGTGAAGACATCCCCTTCCTCGACTACTTCGCCGCCTTCGCGAGGTTGCCGAACCAGGAGCAGTGGGCTCTGCTCGCCGGGCGGGGCGGTGACTTGACGGACCTCTTCCTCGAGCAACGCGACGCGGCCCTCCGCGAGATCCGAAGGAAGACGGTCCTCGAGGGCGACGTCCTGCGTCTGGACCCATCCGAACTGTTGGCGGCGTGTGCGTCCGTCGAGGACCTCCGGGACCCCGCCTCCATCACCTTCCGCCTTCAGTTCTCCAGCGACGGGGGGACCCGGAGCCGCAGACAGCCGGTGGTGAACGGGGTCTTCACCGGTTTCGGTGCCTTCTACTCGAGGTTCAGCGACTTCGTCCCGGGCACGAACGACGACTGGTCACTGCGCTCATCTCTGCGTCGGCACATCGGTCGGACTTTTCCGGACCAGACCGACCTACACGCCGTCCTCGGGTTCAACTTCAACCTGCACCCGCCGCTGACCGACCGGTCTGTGCTCTACCCGGGGAGCGTCGCGAGCGGCGGTTCCCAAGAGTTCCTCGGCCTCGACGGACTGCGGCTGCGGGTCGACCACGAGAGCAGGTCGCTGCTGCTCTGGGACCCCCTACAGGACCGTCGCGTCGACCTGCTGCCGATGAACTTCCTGCTCCCCGTCAACGCGCCCCTGCTGTACCAGGTGCTCGACGCGCTCAGCCCCACGGTCTTCTCGACCTGGCAGCCGGTGAACGACATGCGCAATTGCGGGTACTTCGAGTCCCTACCCGAGTCCTTCCACCGCCTAGAGGTCGGGGACGTGGTCGCCGACCGTAGGACATGGACGGTTCCAGCGGAAGACGTCCCCGGCCTGGAGGACCTGAGCCGGGACTCCTATGAGGCCCTCCTGCGCTTCGACGAGTGGCGCCGTGCACGGGGCCTGCCCCGGCACGCTTTCGTCATGTGCCGGACACTCGACGAGTTCAACACGCTCACCGGCCGGATGACGGACATGTCGAAGGTCTGGGGCGAACTGGCGAACCTGAACCGGGCGAGCGTGCACAAGCCTATGTACGTGGACTTCCGCAACCCCTACCTGGTTCGCAGCTTCGCGAGGTCGGCGACGTCGCGGTCGGGCGTCTTCGTCTCGGTCACCGAGTGCCTGCCGGCCGTGGAGGACTACGCCGATGACCCCGACATCACCGCCACAGAGGAGTTCTTCGTTGAGCTTTACCGAGACCGGGACTGA	MAWGSAFLLKGKRSPPFHVLTERFLTGCSMSVNVSPYVLFRRNRIPVSEVACINFGDSWSGIDGANILRAEAEKFADSLSSLLAGIVPETEKPVRSKIVQLRRDVHNGRHERVVSRASELRPYLGERIFGEIQDWVEASEGAYHREKEAREAFAREQEEARAAFTSLFGYEAIGKSIQLSGGQLYQSLLNYVEQGPGAFKPSKVRNFESTLVNYVYRASLKPSPFGWFTEVGAFPADLGQGNRADGEDEGTGSPVGPAAAATVADGDASVAKLNVFLMNWIVGALTGVPGGWGVGVFLLNPTVRVDGEQIEFSGTSNESFLQGRIHGEMVRIKRDRVVECLLELLSGGPRAAADVAGALADATGDEGYARRILTALMRVGLVFFRVDIDDQDAEYSRKFEELLREGGTPQLARLADEFSALREVEAGLPGATIPEREALLLSAQRSVSAIAEACGTTLPPEVMMRSPVYEDVPTRTRPRTWSPETVTGGLDALEGLWRFSSLLEQGQTKRLALYAFAVQSFGDREDIPFLDYFAAFARLPNQEQWALLAGRGGDLTDLFLEQRDAALREIRRKTVLEGDVLRLDPSELLAACASVEDLRDPASITFRLQFSSDGGTRSRRQPVVNGVFTGFGAFYSRFSDFVPGTNDDWSLRSSLRRHIGRTFPDQTDLHAVLGFNFNLHPPLTDRSVLYPGSVASGGSQEFLGLDGLRLRVDHESRSLLLWDPLQDRRVDLLPMNFLLPVNAPLLYQVLDALSPTVFSTWQPVNDMRNCGYFESLPESFHRLEVGDVVADRRTWTVPAEDVPGLEDLSRDSYEALLRFDEWRRARGLPRHAFVMCRTLDEFNTLTGRMTDMSKVWGELANLNRASVHKPMYVDFRNPYLVRSFARSATSRSGVFVSVTECLPAVEDYADDPDITATEEFFVELYRDRD	MKRSFFMLKTKITSSILVGACLLIGCSNGNEQPVSNEPEPEESVETGEAVFKALEEEYAARLGVFALDTGTGQTVSYRSDERFTYASAHKPLAVAVLLQQKSIEELEQLITYSADDLVNYNPITENHVETGMTLRELSDASIRYSDNTAANFIFDEIGGPEGFKEGLRAIGDTVTEPERIEPELNHVEPGEIQDTSTPEALAKSLQEFALGEALPADKQELLIDWLIGNTTGDALIRAGVPEGWEVGDKTGAGSYGTRNDIAILWPPEKEPIILAVLSSKDEKDAEYDDELIAKATEEVINLLAQTE	302.61	gnl|BL_ORD_ID|2374|hsp_num:0	3559			567	741	
BGC0000615.1|TP-1161_15 # 25033 # 25965 # 1 # ID=1_15;partial=00;start_type=TTG;rbs_motif=AGAG;rbs_spacer=10bp;gc_cont=0.676	BGC0000615.1|TP-1161_15 	25033	25965	+	Loose	400	26.1794	Pseudomonas aeruginosa CpxR	33.33	3004054	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; monobactam; aminoglycoside antibiotic; carbapenem; cephalosporin; cephamycin; penam; tetracycline antibiotic; peptide antibiotic; aminocoumarin antibiotic; diaminopyrimidine antibiotic; sulfonamide antibiotic; phenicol antibiotic; penem	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	TTGAGCTTTACCGAGACCGGGACTGAGACCGCGGAGAGGGCTGAGTGGTTCGCGGTCCACGTGTACCTGCCCTACTCACTGCAGACCGCCTTCCTATGTGAAGACGTGGCGCCTCTGGTCGGGGACCTGGGGGCACGCGGTCGCTTCTTCTTCCTGCGCTACTGGAAGGGCGGGCCGCACCTGCGGCTCCGGTTCGACGGTCGCCACACGCAGGTCGGTCCTGAGGAGGTCGTCGAGCGTCTGGAGTCGCTGGTCCCCCACGGGGACCAGGAGGCCAGGGGCCAGTACGACCTCCAGGCCGCTTCCCAGGCCGGACTTGCTCGTATGGAGAACGAGGAGGTCATGGCGGCCAGGCCCTTCGGTGCCGTGGAGCGCTTCGACTACCTCCCCGAGTACGACAAGTACGGCGGGCCACAGGGGATCGAGATCGCCGAGACCGTGTTCTGTGACACCTCGGGGGCGGTCTTGGACCTCCTGGCGGCCACCAGGAGGTCGACCACGATGCCCGTCGGCGAGGCAGTGCGGGCCATGGCCATGTCCCTGCGCGGCGTGGGCTTGAGCGCGGAGGAGAGTGTCCCCTTGCTGCGCGGCTACGAACAGCGGTGGAGCGCCTTCCTGCCGGAGAGCTCCGATGCCGGTTGGAACTCCATGTACGACAAGGCGAGGGACGGTCTGGTGAACATGTGCAGAAAGATCTGGGGCCCGACCGAGGGCGACGCCTTCTCCGATGCCTACGCGACCGCGACCGCGAGGGCCCGGGCGCTGTTCGGGGAGGGGCCCGACCAGAGGTTGACCGACATCAGGATGCCGGGAACCTCCTACATGGAGTGCGTGGCGCAGTACCTCCACACGACCAACAACCGCCTGGGGCTGGTCCCCGCAGGTGAGGCGCTCGCGGCCCATCTCATGCACTGTGCCCTCCGGGAGCTGTGA	MSFTETGTETAERAEWFAVHVYLPYSLQTAFLCEDVAPLVGDLGARGRFFFLRYWKGGPHLRLRFDGRHTQVGPEEVVERLESLVPHGDQEARGQYDLQAASQAGLARMENEEVMAARPFGAVERFDYLPEYDKYGGPQGIEIAETVFCDTSGAVLDLLAATRRSTTMPVGEAVRAMAMSLRGVGLSAEESVPLLRGYEQRWSAFLPESSDAGWNSMYDKARDGLVNMCRKIWGPTEGDAFSDAYATATARARALFGEGPDQRLTDIRMPGTSYMECVAQYLHTTNNRLGLVPAGEALAAHLMHCALREL	MSELLLIDDDRELCELLGTWLVQEGFSVRASHDGAQARRALAEQTPDAVVLDVMLPDGSGLELLKQLRGDHPDLPVLMLSARGEPLDRILGLELGADDYLAKPCDPRELTARLRAVLRRTHPAQPSAQMQLGDLSLNLTRGVAQIDGQEISLTLSESRILEALLRQPGEPLDKQALAQLALGRKLTLYDRSLDMHVSNLRKKLGSHPDGSPRILALRGRGYYYSH	137.78	gnl|BL_ORD_ID|2300|hsp_num:0	2685			57	198	erythromycin; ciprofloxacin; tetracycline; ceftazidime; ceftriaxone; meropenem; novobiocin; azithromycin; trimethoprim; sulfamethoxazole; chloramphenicol; aztreonam; colistin A; colistin B; ampicillin; panipenem; trimethoprim-sulfamethoxazole
BGC0000615.1|TP-1161_16 # 26395 # 26766 # 1 # ID=1_16;partial=00;start_type=GTG;rbs_motif=AGA;rbs_spacer=10bp;gc_cont=0.645	BGC0000615.1|TP-1161_16 	26395	26766	+	Loose	2030	24.2534	ceoB	29.41	3003010	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; aminoglycoside antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGCCCACCATCCAGCAGCTGGTCCGTAAGGGCCGACAGGACAAGGTCGCAAAGAACAAGACCCCGGCGCTGAAGGGGAGTCCGCAGCGTCGTGGTGTGTGCACTCGTGTCTACACCACCACGCCCAAGAAGCCGAACTCCGCTCTGCGTAAGGTCGCTCGCGTCAAGCTGAGCAGCGGCATCGAGGTCACGGCCTACATCCCCGGCATCGGCCACAACCTCCAGGAGCACAGCATCGTGCTGGTTCGTGGCGGTCGTGTGAAGGACCTGCCGGGTGTCCGCTACCGAATTGTCCGCGGTTCGCTCGACACCCAGGGCGTCCGGGGCCGCAAGCAGGCCCGTAGCCACTACGGCGCCAAGAAGGAGAAGTAA	MPTIQQLVRKGRQDKVAKNKTPALKGSPQRRGVCTRVYTTTPKKPNSALRKVARVKLSSGIEVTAYIPGIGHNLQEHSIVLVRGGRVKDLPGVRYRIVRGSLDTQGVRGRKQARSHYGAKKEK	MNISKFFIDRPIFAGVLSVIILLGGVIAMFLLPISEYPEVVPPSVIVKAQYPGANPKVIAETVASPLEEQINGVENMLYMQSQANSDGNMTITVTFKLGTDPDKATQLVQNRVNQALPRLPEDVQRLGITTVKSSPTLTMVVHLISPDNRYDMTYLRNYALINVKDRLSRIQGVGQVQLWGSGDYAMRVWLDPQKVAQRGLSAEDVVQAIREQNVQVAAGVIGASPSLPGTPLQLSVNARGRLQTEDEFGDIVVKTTPDGGVTHLRDIARIQLDASEYGLRSLLDNKPAVAMAINQSPGANSLQISDEVRKTMAELKQDMPAGVDYKIVYDPTQFVRSSIKAVVHTLLEAIALVVIVVIVFLQTWRASLIPLIAVPVSIIGTFSLLLAFGYSINALSLFGMVLAIGIVVDDAIVVVENVERNIENGMNARQATYKAMQEVSGPIIAIALTLVAVFVPLAFMSGLTGQFYKQFAMTIAISTVISAFNSLTLSPALSAILLKGHGDKEDWLTRVMNRVLGGFFRGFNKVFHRGAENYGRGVRGVLSRKTLMLGVYLVLVGATVLVSKVVPGGFVPAQDKEYLIAFAQLPNGASLDRTEKVIRDMGSIALKQPGVESAVAFPGLSVNGFTNSSSAGIVFVTLKPFAERHGKALSAGAIAGALNQKYGAMKDSFVAVFPPPPVLGLGTLGGFKMQIEDRGAVGYAKLSDATNDFIKRAQQAPELGPLFTSYQINVPQLNVDLDRVKAKQLGVPVTDVFNTMQVYLGSLYVNDFNRFGRVYQVRVQADAPFRQRADDILQLKTRNDKGEMVPLSSLVTVTPTFGPEMVVRYNGYTAADINGGPAPGFSSGQAQAAVERIADETLPRGVRFEWTDLTYQQILAGDSAMWVFPISVLLVFLVLAALYESLTLPLAVILIVPMSILSALTGVWLTQGDNNIFTQIGLMVLVGLSAKNAILIVEFARELEHDGRTPLEAAIEASRLRLRPILMTSIAFIMGVVPLVTSTGAGSEMRHAMGVAVFFGMLGVTLFGLI	11.98	gnl|BL_ORD_ID|1148|hsp_num:0	1252			672	825	
BGC0000615.1|TP-1161_17 # 26769 # 27239 # 1 # ID=1_17;partial=00;start_type=ATG;rbs_motif=GAGA;rbs_spacer=7bp;gc_cont=0.665	BGC0000615.1|TP-1161_17 	26769	27239	+	Loose	500	25.409	APH(6)-Id	27.45	3002660	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(6)	ATGCCGCGCAAGGGCCCGGCGCCGAAGCGCCAGCTCATCACCGACCCGGTCTACGGCTCGCCGCTCGTCACCGCACTGATCAACAAGGTGCTGCTCGACGGTAAGCGTTCCATCGCTCAGAACGTCGTGTACGGCGCTCTCGAGGGTGCTCGCGAGAAGACCGGACAGGACCCGCTCGTCGTTCTCAAGCGAGCCCTGGACAACGTCAAGCCCGCGCTCGAGGTCCGCAGCCGCCGTGTCGGTGGCGCGACCTACCAGGTGCCGGTCGAGGTTCGCGCCTCCCGGTCCACCACGCTGGCCCTGCGCTGGCTCGTCTCCTACTCGCGTCAGCGTCGTGAGAAGACGATGACCGAGCGTCTGATGAACGAGCTGGTCGACGCCAGCAACGGTCTGGGCGCGGCCGTCAAGAAGCGTGAGGACACGCACAAGATGGCCGAGTCGAACAAGGCCTTCGCCCACTACCGCTGGTAA	MPRKGPAPKRQLITDPVYGSPLVTALINKVLLDGKRSIAQNVVYGALEGAREKTGQDPLVVLKRALDNVKPALEVRSRRVGGATYQVPVEVRASRSTTLALRWLVSYSRQRREKTMTERLMNELVDASNGLGAAVKKREDTHKMAESNKAFAHYRW	MFMPPVFPAHWHVSQPVLIADTFSSLVWKVSLPDGTPAIVKGLKPIEDIADELRGADYLVWRNGRGAVRLLGRENNLMLLEYAGERMLSHIVAEHGDYQATEIAAELMAKLYAASEEPLPSALLPIRDRFAALFQRARDDQNAGCQTDYVHAAIIADQMMSNASELRGLHGDLHHENIMFSSRGWLVIDPVGLVGEVGFGAANMFYDPADRDDLCLDPRRIAQMADAFSRALDVDPRRLLDQAYAYGCLSAAWNADGEQEQRDLAIAAAIKQVRQTSY	56.12	gnl|BL_ORD_ID|950|hsp_num:0	1031			621	774	streptomycin
BGC0000615.1|TP-1161_18 # 27288 # 29399 # 1 # ID=1_18;partial=00;start_type=ATG;rbs_motif=AGA;rbs_spacer=8bp;gc_cont=0.644	BGC0000615.1|TP-1161_18 	27288	29399	+	Loose	1350	796.964	Staphylococcus aureus fusA with mutation conferring resistance to fusidic acid	57.0	3003735	protein variant model	V90I	Q125R:2137	fusidane antibiotic	antibiotic target alteration	antibiotic resistant fusA	ATGGCTAAGACTTTGCTTGACCTGGCCAAAGTCCGCAATATCGGCATCATGGCCCACATCGACGCGGGCAAGACCACGACGACCGAGCGGATCCTCTACTACACCGGTGTGAACCACAAGCTCGGCGAGACGCACGATGGCGCCTCGACGATGGACTGGATGAAGGAGGAGCAGGAGCGGGGTATCACCATTACCTCGGCTGCTACCACCACGCACTGGGGCGATCACACGATCAACATCATCGACACGCCCGGCCACGTCGACTTCACCATCGAGGTCGAGCGTTCGCTGCGTGTTCTCGATGGTGCGGTCGCCGTCTTCGACGCCAAGGAAGGCGTCGAGCCGCAGTCGGAGCAGGTCTGGCGTCAGGCCGACCGCTACAACGTTCCCCGTATCTGCTTCGTCAACAAGATGGACAAGATCGGGGCCGATTTCCAGCGTTGTGTCGACATGTTCCGTGAGCGCCTCGGCGCGAACGCCATGCCGATCCAGCTGAACATCGGTGCGGAGAGCGACTTCAAGGGCGTCATCGACCTCGTGAAGATGAAGGCCTACGTCTGGAACGACGAGGCCGCCCTCGGCGAGATGTACGACACCGTCGAGATCCCCGAGAGCCACGCCGACGTCGCCCGCGAGGCCCGCGACTCGTTCATCGAGACGCTGGCCGACGGTGACGACGAGATCATGGAGCTCTACCTCGAGGGCACGGAGCCCACCGAGGACCAGCTCGTGGCCGCGATCCGTCGCGCCACGATCGCCGGCACCGCGATCCCCGTGGTCTGCGGCACCGCCTTCAAGAACAAGGGCGTCCAGCCCCTGCTCGACGCGGTCACCGCCTACCTCCCCTCGCCCCTGGACGTCGAGGCCGTCGAAGGCCACGACCCCAAGGACGAGACCGAGGAGACCAAGCTCGAGCGCAAGCCGAGCGTCGACGAGCCGATGTCCGCCCTGGTCTTCAAGATCATGAGCGACCCGCACCTGGGCAAGCTGACCTACGTGCGCATCTACTCCGGCGTCATCAGCAGCGGTACCCAGGTTCTCAACAGCCTGAAGGGCCGCAAGGAGCGCATCGGCAAGATCTACCGCATGCATTCCAACAAGCGTGAGGAGATCGCCGAGGCCGGCGCCGGTGACATCGTCGCCGTCATGGGTCTGAAGGACACCACGACCGGTGAGACGCTGTGCGACCAGTCGTCCCCGATCGTCCTGGAGTCCATGACCTTCCCGGCTCCGGTCATCGAGGTGGCCATCGAGCCCAAGACCAAGAGCGACCAGGAGAAGCTGGGCATCGCGATCCAGCGTCTGGCCGACGAGGACCCCTCCTTCCAGGTGGCCTCGGACGAGCAGACCGGTCAGACCGTGATCTCGGGCATGGGCGAGCTGCACCTCGAGGTGCTGGTCAACCGCATGCGCGACGAGTTCAAGGTCGAGGCGAACATCGGTAAGCCCCAGGTGGCCTACCGCGAGACCATTCGCAAGAAGGTCGAAGGCCACGTCTACACCCACAAGAAGCAGACGGGTGGTTCGGGTCAGTTCGCCAAGGTCAAGATCGACCTTGAGCCGCTGGAGACCGAAGAGGGCGTCGCCTCGGGTTACGAGTTCGTCAACGCCGTCACCGGTGGCCGCATCCCGCGTGAGTACATCCCGTCGGTCGATGCCGGTTGCCAGGACGCCGCCGAGCTGGGTGTGCTCGCGCACTACCCGCTGGTCGGCATCAAGGTGACGCTCCAGGACGGCCAGTACCACGAGGTCGACTCCTCGGAGATGGCGTTCAAGACCGCCGGTTCGATGGCCTTCAAGGAGGCCGTCCGGCTGGCGAAGCCGACTCTTCTCGAGCCGGTCATGGCCGTCGAGGTCACCACGCCCGAGGAGTACATGGGCGACGTCGTGGGCGACCTGAACTCCCGCCGTGGACAGATCCAGTCCATGGACGAGCGTTCCGGCGTCCGGATCGTCAGGGCCCTGGTGCCCCTCTCGGAAATGTTCGGCTACGTGGGTGACCTGCGCAGCCGTACGCAGGGTCGAGCCAACTACTCGATGGTGTTCGACTCCTACGCGGAGGTTCCGTCCGCTGTCGCCCAAGAAATTGTGGCGAAGGTTCGCGGCGAGTAG	MAKTLLDLAKVRNIGIMAHIDAGKTTTTERILYYTGVNHKLGETHDGASTMDWMKEEQERGITITSAATTTHWGDHTINIIDTPGHVDFTIEVERSLRVLDGAVAVFDAKEGVEPQSEQVWRQADRYNVPRICFVNKMDKIGADFQRCVDMFRERLGANAMPIQLNIGAESDFKGVIDLVKMKAYVWNDEAALGEMYDTVEIPESHADVAREARDSFIETLADGDDEIMELYLEGTEPTEDQLVAAIRRATIAGTAIPVVCGTAFKNKGVQPLLDAVTAYLPSPLDVEAVEGHDPKDETEETKLERKPSVDEPMSALVFKIMSDPHLGKLTYVRIYSGVISSGTQVLNSLKGRKERIGKIYRMHSNKREEIAEAGAGDIVAVMGLKDTTTGETLCDQSSPIVLESMTFPAPVIEVAIEPKTKSDQEKLGIAIQRLADEDPSFQVASDEQTGQTVISGMGELHLEVLVNRMRDEFKVEANIGKPQVAYRETIRKKVEGHVYTHKKQTGGSGQFAKVKIDLEPLETEEGVASGYEFVNAVTGGRIPREYIPSVDAGCQDAAELGVLAHYPLVGIKVTLQDGQYHEVDSSEMAFKTAGSMAFKEAVRLAKPTLLEPVMAVEVTTPEEYMGDVVGDLNSRRGQIQSMDERSGVRIVRALVPLSEMFGYVGDLRSRTQGRANYSMVFDSYAEVPSAVAQEIVAKVRGE	MAREFSLEKTRNIGIMAHIDAGKTTTTERILYYTGRIHKIGETHEGASQMDWMEQEQDRGITITSAATTAAWEGHRVNIIDTPGHVDFTVEVERSLRVLDGAVTVLDAQSGVEPQTETVWRQATTYGVPRIVFVNKMDKLGANFEYSVSTLHDRLQANAAPIQLPIGAEDEFEAIIDLVEMKCFKYTNDLGTEIEEIEIPEDHLDRAEEARASLIEAVAETSDELMEKYLGDEEISVSELKEAIRQATTNVEFYPVLCGTAFKNKGVQLMLDAVIDYLPSPLDVKPIIGHRASNPEEEVIAKADDSAEFAALAFKVMTDPYVGKLTFFRVYSGTMTSGSYVKNSTKGKRERVGRLLQMHANSRQEIDTVYSGDIAAAVGLKDTGTGDTLCGEKNDIILESMEFPEPVIHLSVEPKSKADQDKMTQALVKLQEEDPTFHAHTDEETGQVIIGGMGELHLDILVDRMKKEFNVECNVGAPMVSYRETFKSSAQVQGKFSRQSGGRGQYGDVHIEFTPNETGAGFEFENAIVGGVVPREYIPSVEAGLKDAMENGVLAGYPLIDVKAKLYDGSYHDVDSSEMAFKIAASLALKEAAKKCDPVILEPMMKVTIEMPEEYMGDIMGDVTSRRGRVDGMEPRGNAQVVNAYVPLSEMFGYATSLRSNTQGRGTYTMYFDHYAEVPKSIAEDIIKKNKGE	101.44	gnl|BL_ORD_ID|4695|hsp_num:0	2254			12	2079	fusidic acid
BGC0000615.1|TP-1161_19 # 29483 # 30676 # 1 # ID=1_19;partial=00;start_type=GTG;rbs_motif=GAGA;rbs_spacer=6bp;gc_cont=0.652	BGC0000615.1|TP-1161_19 	29483	30676	+	Loose	700	593.193	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin	74.75	3003369	protein variant model	R234F	n/a	elfamycin antibiotic	antibiotic target alteration	elfamycin resistant EF-Tu	GTGGCGAAGGAAAAGTTCGAGCGGACCAAGCCGCACGTCAACATCGGCACCATCGGTCACATTGACCACGGCAAGACCACGCTGACCGCCGCGATCAGCAAGGTGCTGCACGACGCGTTCCCCGACCTGAACCCGTTCACCCCGTTCGAGGACATCGACAACGCTCCCGAGGAGCGCGAGCGCGGCGTCACGATCTCGGTCTCGCACATCGAGTACCAGACCGAGGCGCGTCACTACGCCCACGTCGACTGCCCCGGTCACGCCGACTACGTGAAGAACATGATCACGGGTGCGGCGCAGATGGACGGCGCCATCCTGGTCGTGGCCGCCACCGACGGCCCGATGCCGCAGACCAAGGAGCACGTGCTCTTGGCCCGCCAGGTCGGCGTGCCCTACATCGTGGTGGCCCTGAACAAGGCCGACATGGTGGACGACGAGGAGATCTTCGAGCTCGTCGAGCTCGAGGTGCGTGAGCTCCTCAGCGAGTACGAGTTCCCCGGTGACGACATCCCCGTCACCAAGGTCTCCGCGCTCAAGGCCCTCGAGGGCGACGCCGAGTGGGGCAAGACCGTCCTGGAGCTCATGGGCACCGTGGACCAGTACATCCCCGAGCCCGAGCGTGACACCGACAAGCCGTTCCTGATGCCGATCGAGGACGTCTTCTCGATCACCGGTCGCGGCACCGTCGTCACCGGTCGTATCGAGCGCGGTATCGTCAACGTGAACGAGACCGTCGACATCGTCGGCATCAAGGAAGAGAAGCAGTCCACCACCGTCACCGGTGTTGAGATGTTCCGCAAGCTTCTCGACCAGGGCCAGGCCGGTGACAACGTCGGTCTGCTCCTGCGCGGCATCAAGCGCGAGGACGTCGAGCGCGGCCAGGTCGTCATCAAGCCCGGCACCACCACGCCGCACACCGAGTTCGAGGGCCAGGTCGTCATCCTGTCCAAGGACGAGGGTGGCCGCCACACGCCGTTCTTCAACAACTACCGCCCGCAGTTCTACTTCCGCACCACCGACGTCACCGGCGTCGTGACGCTGCCGGAGGGCACCGAGATGGTCATGCCCGGTGACAACACCGCGATGACCGTCCAGCTCATCCAGCCGGTCGCCATGGAAGAGGGCCTCAAGTTCGCCATCCGTGAGGGTGGCCGGACCGTGGGCGCGGGTCGCGTCACCAAGATCCTCAAGTAG	MAKEKFERTKPHVNIGTIGHIDHGKTTLTAAISKVLHDAFPDLNPFTPFEDIDNAPEERERGVTISVSHIEYQTEARHYAHVDCPGHADYVKNMITGAAQMDGAILVVAATDGPMPQTKEHVLLARQVGVPYIVVALNKADMVDDEEIFELVELEVRELLSEYEFPGDDIPVTKVSALKALEGDAEWGKTVLELMGTVDQYIPEPERDTDKPFLMPIEDVFSITGRGTVVTGRIERGIVNVNETVDIVGIKEEKQSTTVTGVEMFRKLLDQGQAGDNVGLLLRGIKREDVERGQVVIKPGTTTPHTEFEGQVVILSKDEGGRHTPFFNNYRPQFYFRTTDVTGVVTLPEGTEMVMPGDNTAMTVQLIQPVAMEEGLKFAIREGGRTVGAGRVTKILK	MLSPEGESTIVRNIAVSKEKFERTKPHVNVGTIGHVDHGKTTLTAAITTVLAKTYGGAARAFDQIDNAPEEKARGITINTSHVEYDTPTRHYAHVDCPGHADYVKNMITGAAQMDGAILVVAATDGPMPQTREHILLGRQVGVPYIIVFLNKCDMVDDEELLELVEMEVRELLSQYDFPGDDTPIVRGSALKALEGDAEWEAKILELAGFLDSYIPEPERAIDKPFLLPIEDVFSISGRGTVVTGRVERGIIKVGEEVEIVGIKETQKSTCTGVEMFRKLLDEGRAGENVGVLLRGIKREEIERGQVLAKPGTIKPHTKFESEVYILSKDEGGRHTPFFKGYRPQFYFRTTDVTGTIELPEGVEMVMPGDNIKMVVTLIHPIAMDDGLRFAIREGGRTVGAGVVAKVLG	97.07	gnl|BL_ORD_ID|1970|hsp_num:0	2158			45	1224	pulvomycin
